Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Functional comparison of native and recombinant human salivary histatin 1.

Driscoll J, Zuo Y, Xu T, Choi JR, Troxler RF, Oppenheim FG.

J Dent Res. 1995 Dec;74(12):1837-44.

PMID:
8600179
2.

Physical parameters of hydroxyapatite adsorption and effect on candidacidal activity of histatins.

Yin A, Margolis HC, Grogan J, Yao Y, Troxler RF, Oppenheim FG.

Arch Oral Biol. 2003 May;48(5):361-8.

PMID:
12711380
3.

Candidacidal activity of human salivary histatin recombinant variants produced by site-directed mutagenesis.

Driscoll J, Duan C, Zuo Y, Xu T, Troxler R, Oppenheim FG.

Gene. 1996 Oct 24;177(1-2):29-34.

PMID:
8921841
4.

Recombinant histatins: functional domain duplication enhances candidacidal activity.

Zuo Y, Xu T, Troxler RF, Li J, Driscoll J, Oppenheim FG.

Gene. 1995 Aug 8;161(1):87-91.

PMID:
7642143
5.
6.

Construction and characterization of human salivary histatin-5 multimers.

Situ H, Tsai H, Bobek LA.

J Dent Res. 1999 Feb;78(2):690-8.

PMID:
10029468
7.
9.

Characterization of histatin 5 with respect to amphipathicity, hydrophobicity, and effects on cell and mitochondrial membrane integrity excludes a candidacidal mechanism of pore formation.

Helmerhorst EJ, van't Hof W, Breeuwer P, Veerman EC, Abee T, Troxler RF, Amerongen AV, Oppenheim FG.

J Biol Chem. 2001 Feb 23;276(8):5643-9. Epub 2000 Nov 30. Erratum in: J Biol Chem 2001 May 18;276(20):17620.

11.

Expression of human salivary histatin and cystatin/histatin chimeric cDNAs in Escherichia coli.

Bobek LA, Tsai H, Levine MJ.

Crit Rev Oral Biol Med. 1993;4(3-4):581-90.

PMID:
8374011
12.
13.

Candidacidal activity of recombinant human salivary histatin-5 and variants.

Tsai H, Raj PA, Bobek LA.

Infect Immun. 1996 Dec;64(12):5000-7.

14.
15.

Stabilization of helix by side-chain interactions in histatin-derived peptides: role in candidacidal activity.

Ramalingam K, Gururaja TL, Ramasubbu N, Levine MJ.

Biochem Biophys Res Commun. 1996 Aug 5;225(1):47-53.

PMID:
8769093
16.

Human salivary histatins: promising anti-fungal therapeutic agents.

Tsai H, Bobek LA.

Crit Rev Oral Biol Med. 1998;9(4):480-97. Review.

PMID:
9825223
17.

Killing of Candida albicans by histatin 5: cellular uptake and energy requirement.

Gyurko C, Lendenmann U, Helmerhorst EJ, Troxler RF, Oppenheim FG.

Antonie Van Leeuwenhoek. 2001 Sep;79(3-4):297-309.

PMID:
11816973
18.

The cellular target of histatin 5 on Candida albicans is the energized mitochondrion.

Helmerhorst EJ, Breeuwer P, van't Hof W, Walgreen-Weterings E, Oomen LC, Veerman EC, Amerongen AV, Abee T.

J Biol Chem. 1999 Mar 12;274(11):7286-91.

19.

Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5.

Gyurko C, Lendenmann U, Troxler RF, Oppenheim FG.

Antimicrob Agents Chemother. 2000 Feb;44(2):348-54.

20.

Facile expression and purification of the antimicrobial peptide histatin 1 with a cleavable self-aggregating tag (cSAT) in Escherichia coli.

Xing L, Xu W, Zhou B, Chen Y, Lin Z.

Protein Expr Purif. 2013 Apr;88(2):248-53. doi: 10.1016/j.pep.2013.01.012. Epub 2013 Feb 9.

PMID:
23403143

Supplemental Content

Support Center